Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis
Event:
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic:
Cancer/Cardiotoxicity
Session:
Comorbodities
